Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Psychopharmacology (Berl). 2008 Nov 25;203(3):539–546. doi: 10.1007/s00213-008-1401-7

Table 1.

Potencies and antagonism of the ataxic and myorelaxant effects of benzodiazepine-type drugs by βCCT in squirrel monkeys

ED50 mean mg/kg ± SEM)
Drug Alone + βCCT (3.0 mg/kg) Dose Ratioa (mean ± SEM) P<0.05?b
Ataxia
   lam 0.07 ± 0.01 0.3 ± 0.05 4.0 ± 0.50 Yes
 Alprazolam 0.3 ± 0.03 0.8 ± 0.08 2.7 ± 0.27 Yes
   Diazepam 2.6 ± 0.8 8.8 ± 0.5 3.6 ± 0.73 Yes
Chlordiazepoxide 11± 7.1 >56 > 3.0
 Zolpidem 3.0 ± 0.9 16 ± 1.2 6.0 ± 1.1 Yes
   Zaleplon 3.3 ± 0.3 15 ± 1.6 4.5 ± 0.8 Yes
Muscle Resistance
   Triazolam 0.09 ± 0.01 0.1 ± 0.01 1.1 ± 0.1 No
 Alprazolam 0.2 ± 0.02 0.3 ± 0.00 1.5 ± 0.3 No
   Diazepam 1.7 ± 0.2 4.4 ± 1.7 2.3 ± 0.8 No
Chlordiazepoxide 27 ± 2.8 41 ± 0.00 1.5 ± 0.2 No
 Zolpidem 8.8 ± 0.8 7.6 ± 0.9 0.9 ± 0.2 No
 Zaleplon 9.0 ± 0.7 9.2 ± 0.8 1.0 ± 0.4 No

ED50 is the dose of drug resulting in 50% of the maximum effect.

a

Dose ratio = agonist + βCCT ED50 divided by agonist alone ED50.

b

Difference between agonist and agonist + βCCT, Student’s t-tests.